Three Doses of mRNA COVID-19 Vaccines Effective Against Hospitalizations for Omicron and Delta
A nationwide study from the Centers for Disease Control and Prevention (CDC) has found that mRNA booster shots (either Pfizer ...
Tag: Vaccines
How Effective Are Vaccines Against Omicron?
The pandemic has brought many tricky terms and ideas from epidemiology into everyone’s lives. Two particularly complicated concepts are vaccine ...
Streamlined Tool Could Help Reduce Airborne Exposure to COVID in Homes
Leveraging ventilation and filtration has been an underutilized strategy for many residents throughout the pandemic because of the technical know-how ...
Vaccinated People Clear COVID Faster, Less Time with High Virus Levels
A vaccinated person is less likely to get COVID in the first instance, is less contagious, and is contagious for ...
Does AstraZeneca’s COVID Vaccine Give Longer-Lasting Protection Than mRNA Shots?
Last week, AstraZeneca’s chief executive officer said the company’s COVID vaccine may provide longer-lasting protection than mRNA vaccines like Pfizer’s, ...
How Well Do Covid Vaccines Hold Up Over Time? Macaque Study Shows Decline in Lung Protection
The findings point to the need for mRNA-1273 booster vaccination to sustain high-level and rapid protection in the lung and ...
Why Moderna Won’t Share Rights to the COVID-19 Vaccine with the Government That Paid for Its Development
A quiet monthslong legal fight between the U.S. National Institutes of Health and drugmaker Moderna over COVID-19 vaccine patents recently ...
Is COVID-19 Here to Stay? What It Means for a Virus to Become Endemic
Now that kids ages 5 to 11 are eligible for COVID-19 vaccination and the number of fully vaccinated people in ...
Nose Sprays, Needle-Free Patches, Durable Immunity: Towards the Next Generation of COVID Vaccines
The past 20 months has seen an explosion of vaccine development, with COVID vaccine testing and rollout happening at an ...
Vaccination Offers Higher Protection Than Previous COVID-19 Infection
In this multistate analysis of hospitalizations for COVID-19–like illness among adults aged 18 years or older during January–September 2021 whose ...
A Pediatrician Explains How Pfizer’s Covid-19 Vaccine for Ages 5 to 11 Was Tested for Safety and Efficacy
Elementary school children in the United States will soon have one more layer of protection to keep them safe from ...
Rwanda and Senegal Will Host Africa’s First COVID-19 Vaccine Manufacturing Plants
The lack of vaccine production capacity in African countries has been the subject of much concern and hand-wringing in the ...
Navigating New Federal Rules on ‘Mix-and-Match’ Vaccine Booster Shots
Many Americans now have the green light to get a COVID-19 vaccine booster – and the flexibility to receive a ...
Data Shows Continued Vulnerability of Vaccinated Blood Cancer Patients to COVID-19
Vulnerable groups not mounting sufficient immune responses to vaccination (such as blood cancer patients) urgently require the public to continue ...
How a BBQ Lighter Sparked a Breakthrough Idea on Vaccine Delivery
Inspiration for an innovative vaccine delivery method came from an everyday device that people use to start a grill: the ...
Erica Ollmann Saphire Receives $2.6M Grant to Collaborate on Pan-Coronavirus Vaccine
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus ...
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
Moderna COVID Booster Study in Rhesus Macaques Shows Increased Antibody Response
NIH researchers evaluated the immune responses in nonhuman primates that received a primary vaccination series of mRNA-1273 (Moderna) and were ...
GeoVax Receives Patent for VLP Ebola Vaccine
GeoVax Labs, Inc. today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent ...
Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine
Dynavax Technologies Corporation and the U.S. Department of Defense (DOD) today announced an agreement for approximately $22 million over two and a half years to ...
